case_images: PMC11334126_01
case_images: (a) At baseline. (b) After two cycles of IVIg, partial response with post-inflammatory brownish macules. (c) After seven cycles of IVIg, complete response. (d) Five months after discontinuation of IVIg, patient still in remission.. IVIg: intravenous immunoglobulins.
case_images: 10.1177_2050313X241274888-fig1.jpg
case_images: PMC11334126_01_10.1177_2050313X241274888-fig1.jpg
case_images: fig1-2050313X241274888
case_images: In the last 2 years, similar lesions have appeared on her periorbital skin, temples, cheeks, and chin (Figure 1(a)). After two cycles, most active lesions have disappeared with the presence of post-inflammatory brownish macules (Figure 1(b)). After seven cycles, there was complete resolution of the lesions and IVIg was discontinued (Figure 1(c)). Five months after treatment discontinuation (12 months after starting IVIg), the patient was still in remission (Figure 1(d)).